“
TL;DR
It describes the pathophysiology of CFRD, noting that pancreatic damage begins in infancy and insulin secretion defects progress with age, leading to CFRD in 20% of teens and up to half of adults with CF.
Diabetes Care · 20 authors, 21 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
It describes the pathophysiology of CFRD, noting that pancreatic damage begins in infancy and insulin secretion defects progress with age, leading to CFRD in 20% of teens and up to half of adults with CF.
It describes the pathophysiology of CFRD, noting that pancreatic damage begins in infancy and insulin secretion defects progress with age, leading to CFRD in 20% of teens and up to half of adults with CF. The report emphasizes that chronic complications like microvascular and macrovascular disease are understudied in CFRD, and their burden may increase as the CF population ages, particularly with the introduction of CFTR modulator therapies. The workshop outlines a research agenda focused on defining the incidence of complications, examining health disparities, and developing specialized training for healthcare providers.